CAS: 165377-44-6 - 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine dihydrochloride
Formula:C23H34Cl2N2O2
InChI:InChI=1S/C23H32N2O2.2ClH/c1-26-22-11-10-21(19-23(22)27-2)12-14-25-17-15-24(16-18-25)13-6-9-20-7-4-3-5-8-20;;/h3-5,7-8,10-11,19H,6,9,12-18H2,1-2H3;2*1H
InChI key:InChIKey=XWOXAKBQEMQMFH-UHFFFAOYSA-N
SMILES:Cl.O(C1=CC=C(C=C1OC)CCN2CCN(CC2)CCCC=3C=CC=CC3)C
- Synonyms:
- 1-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine hydrochloride (1:2)
- Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-, dihydrochloride
- Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-, hydrochloride (1:2)
- SA-4503 dihydrochloride
- Sa-4503
Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-, hydrochloride (1:2)
CAS:165377-44-6
Formula:
C23H34Cl2N2O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
441.4343
Ref: IN-DA001W4C
1mg | 55.00 € | ||
5mg | 123.00 € | ||
10mg | 155.00 € | ||
25mg | 306.00 € | ||
50mg | 570.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Cutamesine dihydrochloride
CAS:165377-44-6
Cutamesine dihydrochloride is a σ1 receptor agonist, selective over σ2, combating cardiomyocyte hypertrophy and improving …
Formula:
C23H32N2O2·2HCl
Purity:
98.83% - 99%
Color and Shape:
Solid
Molecular weight:
441.43
Ref: TM-T3597
2mg | 43.00 € | ||
5mg | 62.00 € | ||
10mg | 99.00 € | ||
25mg | 220.00 € | ||
50mg | 418.00 € | ||
100mg | 618.00 € | ||
500mg | 1,291.00 € | ||
1mL*10mM (DMSO) | 115.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
SA 4503 Dihydrochloride
Controlled ProductCAS:165377-44-6
Formula:
C23H32N2O2·HCl
Color and Shape:
Neat
Molecular weight:
368.51 + 2(36.46)
Ref: TR-S139590
10mg | 164.00 € | ||
50mg | 519.00 € | ||
100mg | 909.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
SA4503 dihydrochloride
Controlled ProductCAS:165377-44-6
Sigma-1 (Ï1) receptor agonist
Formula:
C23H34Cl2N2O2
Purity:
Min. 95%
Molecular weight:
441.43 g/mol
Ref: 3D-FD32916
1g | To inquire |
Estimated delivery in United States, on Thursday 9 Jan 2025